Found 6 articles for: "Cardiovascular"
Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort
August 2026 | Volume 25 | Issue 8 | Editorials | 760 | Copyright © August 2026
Baricitinib-Related Adverse Events in Alopecia Areata and Rheumatoid Arthritis: A Comparative Study
March 2026 | Volume 25 | Issue 3 | Features | 286 | Copyright © March 2026
Elevated Atherosclerotic Cardiovascular Disease Risk in Fibrotic Skin Diseases: Insights From a TriNetX Cohort Study
November 2025 | Volume 24 | Issue 11 | Original Article | 1121 | Copyright © November 2025
Background: Identifying the risk of atherosclerotic cardiovascular disease (ASCVD) is a cornerstone of preventive medical care. Despite its significance, limited research has exp...
Read MoreExploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1075 | Copyright © November 2025
Background: Nicotinamide (niacinamide) is the water-soluble form of vitamin B3. Nicotinamide plays a crucial physiological role as a catalyst for various molecular reactions in t...
Read MoreIs Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis
May 2025 | Volume 24 | Issue 5 | Original Article | 530 | Copyright © May 2025
Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition associated with risk of cardiovascular disease (CVD), potentially mediated by persistent systemic infl...
Read MoreRecombinant Zoster Vaccine Reduces 3-Year Cardiovascular Risk: Insights From a Multi-Centered Database
December 2023 | Volume 22 | Issue 12 | Original Article | 1178 | Copyright © December 2023
Background: Herpes zoster increases the risk for stroke and myocardial infarction. Zoster vaccination's impact on this risk is understudied. This retrospective work sought to det...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
